Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of glycine transporter inhibitors for the treatment of neurological disorders such as schizophrenia and depression. Its structure supports enhanced blood-brain barrier penetration, making it valuable in central nervous system drug design. Also employed in the preparation of bioactive molecules and peptidomimetics due to its conformational rigidity and functional group compatibility.